Does GLIMEPIRIDE Cause Disseminated intravascular coagulation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disseminated intravascular coagulation have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 0.2% of all adverse event reports for GLIMEPIRIDE.
11
Reports of Disseminated intravascular coagulation with GLIMEPIRIDE
0.2%
of all GLIMEPIRIDE reports
4
Deaths
9
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From GLIMEPIRIDE?
Of the 11 reports, 4 (36.4%) resulted in death, 9 (81.8%) required hospitalization, and 6 (54.5%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does GLIMEPIRIDE Cause?
Hypoglycaemia (1,403)
Blood glucose increased (446)
Acute kidney injury (339)
Drug ineffective (339)
Diarrhoea (257)
Blood glucose decreased (232)
Lactic acidosis (219)
Glycosylated haemoglobin increased (214)
Diabetes mellitus inadequate control (213)
Hypoglycaemic coma (187)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which GLIMEPIRIDE Alternatives Have Lower Disseminated intravascular coagulation Risk?
GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLIMEPIRIDE vs GLIPIZIDE
GLIMEPIRIDE vs GLIVEC
GLIMEPIRIDE vs GLOFITAMAB
GLIMEPIRIDE vs GLOFITAMAB-GXBM